GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
JUND | hg19_v2_chr19_-_18391708_18391739 | 0.60 | 8.5e-23 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_84035905 Show fit | 21.77 |
ENST00000311507.4
|
placenta-specific 8 |
|
chr4_-_84035868 Show fit | 21.00 |
ENST00000426923.2
ENST00000509973.1 |
placenta-specific 8 |
|
chr3_-_18466026 Show fit | 17.64 |
ENST00000417717.2
|
SATB homeobox 1 |
|
chr5_-_140013275 Show fit | 13.87 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14 molecule |
|
chr22_-_37545972 Show fit | 13.70 |
ENST00000216223.5
|
interleukin 2 receptor, beta |
|
chr15_+_89182178 Show fit | 12.32 |
ENST00000559876.1
|
interferon stimulated exonuclease gene 20kDa |
|
chr16_+_23847339 Show fit | 12.15 |
ENST00000303531.7
|
protein kinase C, beta |
|
chr15_+_89181974 Show fit | 11.99 |
ENST00000306072.5
|
interferon stimulated exonuclease gene 20kDa |
|
chr12_+_54891495 Show fit | 10.44 |
ENST00000293373.6
|
NCK-associated protein 1-like |
|
chr1_-_153348067 Show fit | 9.83 |
ENST00000368737.3
|
S100 calcium binding protein A12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 42.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
10.8 | 32.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.4 | 16.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 16.2 | GO:0051225 | spindle assembly(GO:0051225) |
3.5 | 13.9 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
2.0 | 13.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.2 | 13.2 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
4.0 | 12.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.7 | 11.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.6 | 10.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) actin polymerization-dependent cell motility(GO:0070358) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 42.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.5 | 32.3 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 17.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 17.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 16.5 | GO:0001772 | immunological synapse(GO:0001772) |
1.8 | 16.2 | GO:0070652 | HAUS complex(GO:0070652) |
2.8 | 13.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 13.2 | GO:0008305 | integrin complex(GO:0008305) |
0.7 | 10.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 9.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 52.5 | GO:0003682 | chromatin binding(GO:0003682) |
10.8 | 32.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.1 | 15.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 14.4 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
4.6 | 13.9 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
3.4 | 13.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 13.1 | GO:0030295 | protein kinase activator activity(GO:0030295) |
4.0 | 12.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
1.7 | 9.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.5 | 9.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 16.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 14.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 13.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 13.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 12.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 11.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 8.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 6.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 5.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 4.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 39.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 21.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 14.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.2 | 13.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 12.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 12.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 12.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 9.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 8.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 7.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |